Skip to main content
Clinical Trials/NCT03182400
NCT03182400
Recruiting
Not Applicable

Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults

University Hospital, Tours1 site in 1 country450 target enrollmentJune 14, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy Volunteer
Sponsor
University Hospital, Tours
Enrollment
450
Locations
1
Primary Endpoint
ERP amplitude (µV)
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

It is now widely accepted that autism is linked to a developmental disorder and cerebral function.

Our research team (UMR U930 INSERM, François-Rabelais University of Tours, whom Pr F Bonnet-Brilhault is responsible for team "Autism") hypothesizes that atypical sensory information processing, especially auditory and / or visual information, could underly the symptoms observed in autism. A better knowledge of the typical development of the sensory and cognitive processes must therefore make it possible in the long term to identify the abnormalities linked to the autism spectrum disorders (ASD).

Studies in healthy subjects are therefore necessary in order to identify neurophysiological indices of cerebral functioning and to study their evolution during normal development, making it possible in the future to compare with populations of subjects with ASD.

The investigators intend to study the development of all the cognitive processes involved in the processing of sensory and, in particular, auditory and visual information in humans: from low-level perception processes to higher-level cognitive processes (attention, emotion, language, prediction, ...). For this the investigators will use non-invasive neurophysiological explorations (EEG, eye tracking) as well as neuropsychological explorations (Questionnaires or spontaneous language recording).

A better understanding of the pathophysiological mechanisms underlying the symptoms observed in autism could ultimately lead to the development of new specific therapeutic strategies, particularly in the field of exchange and development therapy or cognitive remediation .

Registry
clinicaltrials.gov
Start Date
June 14, 2017
End Date
June 2027
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Between 1 and 60 years-old
  • Able to understand and apply instructions for a task
  • Information of subject or legal representant
  • Informed written consent of subject or legal representant
  • Affiliation to the social security system

Exclusion Criteria

  • Abnormal corrected vision
  • Abnormal audition
  • Known personal neurological pathology
  • Known personal psychiatric problems
  • Identified difficulties for walking, language, or learning
  • Exclusion period because of participation to another experimental protocol
  • Adult with legal protection

Outcomes

Primary Outcomes

ERP amplitude (µV)

Time Frame: 1 hour

analysis of ERP amplitude evoked during EEG recording

Secondary Outcomes

  • pupil size (mm)(1 hour)
  • Reaction times (ms)(1 hour)

Study Sites (1)

Loading locations...

Similar Trials